J Biomed Nanotechnol. 2014 Sep;10(9):2086-106. doi: 10.1166/jbn.2014.1989.
Graphene, as a newly discovered carbon allotrope, has attracted broad interest and intense attention since its discovery for both fundamental research and a vast array of industrial and biomedical applications. Considerable efforts have been devoted to understanding the nano-bio-interfaces of graphene-based materials for exploring their potential biomedical applications, including drug delivery, biosensing, biomedical imaging, stem cell technology, and photothermal therapy. This review summarizes the current studies on the physiological stability, enhanced permeability and retention (EPR) effect, active targeting and drug carrying capability of graphene-based nanomaterials, and it provides a basic understanding about the mechanisms of drug and gene delivery by these nanomaterials. Also reviewed is the recent progress on photosensitizers and theranostics using graphene-based nanomaterials. The biosafety of graphene at the cellular and animal levels is discussed. The challenges and perspectives of the field are addressed.
石墨烯作为一种新发现的碳同素异形体,自发现以来,因其在基础研究和广泛的工业和生物医学应用方面的潜力,引起了广泛的兴趣和强烈的关注。人们投入了大量的精力来理解基于石墨烯的材料的纳米-生物界面,以探索其在生物医学方面的潜在应用,包括药物输送、生物传感、生物医学成像、干细胞技术和光热治疗。本文综述了目前关于基于石墨烯的纳米材料的生理稳定性、增强的通透性和保留(EPR)效应、主动靶向和药物载药能力的研究进展,为这些纳米材料的药物和基因输送机制提供了基本的认识。本文还综述了基于石墨烯的纳米材料在光动力治疗方面的最新进展。讨论了石墨烯在细胞和动物水平的生物安全性。探讨了该领域的挑战和展望。
J Biomed Nanotechnol. 2014-9
Bioconjug Chem. 2014-9-17
Biomed Pharmacother. 2017-8-1
Mater Sci Eng C Mater Biol Appl. 2018-5-4
Nanomedicine (Lond). 2013-10
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015-4-6
Curr Med Chem. 2019
J Control Release. 2017-4-28
Expert Opin Drug Deliv. 2015-4
Chem Biol Interact. 2016-11-20
Molecules. 2021-9-25